Amplifyer Bio

amplifyer.bio

Amplifyer Bio, Inc. is an exciting new startup developing technology of transformative potential for the liquid biopsy field and the product of a collaboration between the labs of Dr. Sangeeta Bhatia, Dr. Chris Love and Dr. Viktor Adalsteinsson at MIT and the Broad Institute. The work has been published in Science and has been presented at leading conferences both in the US and internationally. The company is focused on the development of novel priming agents that in combination with current liquid biopsy diagnostics will improve test performance. Amplifyer’s first program will be focused on increasing cfDNA in blood for cancer diagnostics. This will provide both physicians and patients higher quantity and quality of genomic information related to their cancer, with the aim of improving clinical outcomes.